By: Benzinga
Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
Array BioPharma (NASDAQ: ARRY ), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, today announced the appointment of Michael N. Needle, M.D., to the position of Chief Medical Officer. Dr. Needle, a board certified hematologist
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here